Clinical Trials Sponsored by Parker University

Total 222646 results

Asker & Baerum Hospital
Sahlgrenska University Hospital, Sweden; Rikshospitalet University Hospital; University...

Completed

A 2 Year Trial of Patients With Type 2 Diabetes Focusing on Cardiovascular Diagnostics and Metabolic Control

Type 2 Diabetes Mellitus

Norway
Cumberland Pharmaceuticals
Parke-Davis

Completed

Study of Efficacy & Safety of Oral YM087 in Subjects With Euvolemic or Hypervolemic Hyponatremia

Hyponatremia

Poland, United Kingdom, Germany, Spain, Belgium, France, Netherlands, Italy, Finland
Warner Chilcott

Completed

A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy

Menopause | Vulvovaginal Atrophy | Dyspareunia

United States
Warner Chilcott

Completed

Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Warner Chilcott

Completed

Treatment of Erectile Dysfunction - Long Term Safety and Efficacy

Erectile Dysfunction

United States
Warner Chilcott

Terminated

Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dysfunction

Erectile Dysfunction

United States
Warner Chilcott

Completed

Study of Safety and Efficacy of an Oral Contraceptive

Contraception

United States
Warner Chilcott

Completed

Hormone Replacement Therapy for Use in Postmenopausal Women for Relief of Hot Flushes and Urogenital Symptoms.

Hormone Replacement Therapy

United States
Warner Chilcott

Completed

Study of Safety and Efficacy of an Oral Contraceptive

Prevention of Pregnancy

United States
Warner Chilcott

Completed

Treatment of Moderate to Severe Facial Acne Vulgaris

Acne Vulgaris

United States
Warner Chilcott

Completed

Bioequivalence of Testosterone Reduced-size Patch Relative to the Testosterone Reference Patch

Healthy

United States
Warner Chilcott

Completed

Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido

Hypoactive Sexual Desire Disorder

United States, Canada, Australia
Warner Chilcott

Completed

Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido

Hypoactive Sexual Desire Disorder

Canada, Australia, United States
Warner Chilcott

Completed

Testosterone Therapy in Naturally Menopausal Women With Low Sexual Desire Receiving Transdermal Estrogen

Hypoactive Sexual Desire Disorder

Australia, Botswana, Canada, Germany, United Kingdom
Warner Chilcott

Terminated

Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis (CAMPIII)

Ulcerative Colitis

United States, Canada, Croatia, Russian Federation, Poland, Romania
Warner Chilcott

Completed

Treatment of Acne Vulgaris With Doryx Tablets Compared to Doxycyline Hyclate

Acne Vulgaris

United States
Warner Chilcott

Completed

Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis

Ulcerative Colitis

Poland, United States, Croatia, Romania, Canada
Warner Chilcott

Completed

Assess the Safety, Efficacy, and Pharmacokinetics of Immediate and Delayed Release Weekly Risedronate

Postmenopausal Women

United States
Warner Chilcott

Completed

Treatment of Erectile Dysfunction I

Erectile Dysfunction

United States
Warner Chilcott

Completed

Effect of Udenafil on Spermatogenesis

Erectile Dysfunction | Spermatogenesis

United States
Warner Chilcott

Completed

Study of Bleeding With Extended Administration of an Oral Contraceptive

Contraception

United States
Warner Chilcott

Completed

Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women

Vulvovaginal Atrophy

United States
Warner Chilcott

Completed

Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women With Dyspareunia

Vulvovaginal Atrophy

United States
Warner Chilcott

Completed

Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis

Ulcerative Colitis

United States, Canada, Puerto Rico
Warner Chilcott

Completed

Fecal Biomarker Study for Patients With Ulcerative Colitis

Ulcerative Colitis

United States
Warner Chilcott

Completed

A Comparison of Once a Day Dose Compared to 2 Doses/Day

Ulcerative Colitis

United States, Canada, Puerto Rico
Warner Chilcott

Completed

A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis

Postmenopausal Osteoporosis

United States, Estonia, Hungary, Poland, Canada, France, Argentina, Belgium
Warner Chilcott

Completed

Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children

Osteogenesis Imperfecta

Chile, United States, Spain, Australia, Belgium, United Kingdom, Czech Republic, Finland, Germany, Hungary, Italy, Poland, South Africa
Warner Chilcott

Completed

Study of Safety and Efficacy of an Oral Contraceptive

Contraception

United States
Warner Chilcott

Completed

A Double Blind Study for the Treatment of Acute Ulcerative Colitis

Ulcerative Colitis

United States, Canada, Hungary, Belarus, Croatia, Czech Republic, Estonia, Latvia, Lithuania, Poland, Puerto Rico, Romania, Russian Federation, Serbia, Ukraine
Warner Chilcott

Terminated

A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis.

Ulcerative Colitis

United States
Warner Chilcott

Completed

Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido

Hypoactive Sexual Desire Disorder

United States
Warner Chilcott

Completed

Study of the Effect of Once a Week Risedronate on the Microstructure of Tibia and Radius Using a New Scanning Method

Osteopenia

United Kingdom, Argentina, Australia, Canada, France, Germany, Switzerland
Warner Chilcott

Completed

Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women

Hypoactive Sexual Desire Disorder

United States
Warner Chilcott

Completed

Effect of Stopping Risedronate After Long Term Treatment on Bone Turnover

Postmenopausal Women With Osteoporosis

Spain, Australia, Belgium, Denmark, Finland, Italy, Poland, Sweden
Mayo Clinic
Marker Therapeutics, Inc.

Completed

Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer

HER2-positive Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer

United States
Parker Institute for Cancer Immunotherapy
Bristol-Myers Squibb

Completed

Ipilimumab vs Ipilimumab Plus Nivolumab in Patients With Stage III-IV Melanoma Who Have Progressed or Relapsed on PD-1 Inhibitor Therapy

Melanoma

United States
Parker Hughes Cancer Center

Unknown

Monoclonal Antibody Therapy in Treating Patients With Recurrent Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

Lymphoma | Leukemia

United States
University of Pennsylvania
Parker Institute for Cancer Immunotherapy; Tmunity Therapeutics

Terminated

NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells)

Melanoma | Multiple Myeloma | Myxoid/Round Cell Liposarcoma | Synovial Sarcoma

United States
Parker Institute for Cancer Immunotherapy
Seres Therapeutics, Inc.

Completed

Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome Intervention (MCGRAW)

Metastatic Melanoma

United States
Warner Chilcott

Terminated

A Two-week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Years) With Neurogenic Detrusor Overactivity

Neurogenic Detrusor Overactivity

United States, Colombia
Warner Chilcott

Completed

Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream)

Vulvovaginal Atrophy

United States
Warner Chilcott

Completed

Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women (VENUS)

Postmenopausal Vulvovaginal Atrophy

United States
Warner Chilcott

Completed

Delayed Release (DR) Risedronate Compared to Immediate Release (IR) in Postmenopausal Women

Postmenopausal Osteoporosis

United States
Warner Chilcott

Completed

Treatment of Erectile Dysfunction II

Erectile Dysfunction

United States
Warner Chilcott

Completed

Asacol Acute Diverticulitis(DIVA)Study

Diverticulitis

United States
Warner Chilcott

Completed

Study to Assess the Efficacy/Safety of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido

Hypoactive Sexual Desire Disorder (HSDD)

United States, Australia, Canada
Warner Chilcott

Completed

Pharmacokinetics of Asacol 2.4 g/Day and Lialda 2.4 g/Day in Healthy Volunteers

Healthy

United States
Warner Chilcott

Completed

Study of Transdermal Testosterone Patches in Menopausal Women With Low Libido

Hypoactive Sexual Desire Disorder

Australia
Warner Chilcott

Completed

Treatment of Chlamydia Infection Comparing WC2031 Tablets With Vibramycin

Urogential Chlamydia Trachomatis Infection

United States

Clinical Trials Sponsored by Parker University

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malaysia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations